Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Nursing | 3 | 2016 | 101 | 0.830 |
Why?
|
| Breast Neoplasms | 7 | 2019 | 1536 | 0.740 |
Why?
|
| Health Education | 3 | 2012 | 279 | 0.690 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2009 | 300 | 0.650 |
Why?
|
| Neonatal Abstinence Syndrome | 4 | 2019 | 27 | 0.600 |
Why?
|
| Cultural Competency | 2 | 2016 | 42 | 0.600 |
Why?
|
| Professional Competence | 2 | 2016 | 100 | 0.570 |
Why?
|
| Translating | 1 | 2016 | 23 | 0.540 |
Why?
|
| Communication Barriers | 2 | 2016 | 48 | 0.540 |
Why?
|
| Transcultural Nursing | 2 | 2014 | 8 | 0.540 |
Why?
|
| Language | 2 | 2016 | 120 | 0.530 |
Why?
|
| Attitude of Health Personnel | 3 | 2016 | 442 | 0.520 |
Why?
|
| Physician-Patient Relations | 2 | 2016 | 261 | 0.490 |
Why?
|
| Students, Medical | 2 | 2016 | 210 | 0.480 |
Why?
|
| Medicaid | 4 | 2021 | 302 | 0.450 |
Why?
|
| Contraception | 3 | 2022 | 27 | 0.440 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 106 | 0.430 |
Why?
|
| Qualitative Research | 2 | 2022 | 369 | 0.420 |
Why?
|
| Clinical Competence | 2 | 2016 | 657 | 0.420 |
Why?
|
| Patient Care | 1 | 2012 | 61 | 0.410 |
Why?
|
| Rural Population | 3 | 2005 | 398 | 0.410 |
Why?
|
| Medical Oncology | 1 | 2012 | 110 | 0.400 |
Why?
|
| South Carolina | 12 | 2021 | 2752 | 0.380 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2019 | 99 | 0.310 |
Why?
|
| Methadone | 2 | 2018 | 32 | 0.300 |
Why?
|
| Contraceptive Agents | 3 | 2022 | 13 | 0.290 |
Why?
|
| Emigration and Immigration | 2 | 2011 | 33 | 0.250 |
Why?
|
| Southeastern United States | 5 | 2016 | 281 | 0.240 |
Why?
|
| Health Behavior | 2 | 2009 | 458 | 0.240 |
Why?
|
| Survivors | 2 | 2019 | 256 | 0.230 |
Why?
|
| Education, Professional | 1 | 2004 | 25 | 0.230 |
Why?
|
| Preceptorship | 1 | 2004 | 35 | 0.230 |
Why?
|
| Fear | 2 | 2014 | 239 | 0.230 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 123 | 0.220 |
Why?
|
| Attitude to Death | 1 | 2003 | 52 | 0.220 |
Why?
|
| Humans | 28 | 2022 | 68618 | 0.220 |
Why?
|
| Health Services Accessibility | 3 | 2016 | 581 | 0.220 |
Why?
|
| Female | 20 | 2022 | 38074 | 0.210 |
Why?
|
| Rural Health Services | 1 | 2004 | 101 | 0.210 |
Why?
|
| Women's Health | 1 | 2003 | 148 | 0.210 |
Why?
|
| Public Health | 1 | 2004 | 201 | 0.200 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 1242 | 0.200 |
Why?
|
| Counseling | 2 | 2022 | 280 | 0.200 |
Why?
|
| Patient Readmission | 2 | 2021 | 267 | 0.200 |
Why?
|
| Tamoxifen | 2 | 2019 | 62 | 0.190 |
Why?
|
| Adult | 13 | 2021 | 21403 | 0.190 |
Why?
|
| Opiate Substitution Treatment | 2 | 2018 | 57 | 0.180 |
Why?
|
| Peripheral Arterial Disease | 1 | 2021 | 83 | 0.180 |
Why?
|
| Young Adult | 7 | 2021 | 5717 | 0.180 |
Why?
|
| Attitude to Health | 1 | 2003 | 403 | 0.180 |
Why?
|
| Hyperbilirubinemia, Neonatal | 1 | 2020 | 6 | 0.180 |
Why?
|
| Acculturation | 2 | 2011 | 25 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2020 | 159 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 300 | 0.150 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 292 | 0.150 |
Why?
|
| Communication | 2 | 2020 | 329 | 0.150 |
Why?
|
| Cultural Diversity | 2 | 2016 | 67 | 0.150 |
Why?
|
| United States | 9 | 2021 | 7367 | 0.140 |
Why?
|
| Community Health Services | 1 | 2018 | 141 | 0.140 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 298 | 0.140 |
Why?
|
| Cost Savings | 1 | 2017 | 110 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 170 | 0.140 |
Why?
|
| Multilingualism | 1 | 2016 | 14 | 0.140 |
Why?
|
| Technology | 1 | 2016 | 24 | 0.140 |
Why?
|
| Vitamin D | 1 | 2020 | 516 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2011 | 767 | 0.130 |
Why?
|
| Comprehension | 1 | 2016 | 71 | 0.130 |
Why?
|
| Awareness | 1 | 2016 | 81 | 0.130 |
Why?
|
| Telephone | 1 | 2016 | 160 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 154 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2018 | 335 | 0.120 |
Why?
|
| Risk | 1 | 2016 | 563 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 955 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 148 | 0.120 |
Why?
|
| Nursing Evaluation Research | 1 | 2014 | 46 | 0.120 |
Why?
|
| Nursing Education Research | 1 | 2014 | 35 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 202 | 0.120 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.110 |
Why?
|
| Community Networks | 1 | 2013 | 96 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1173 | 0.100 |
Why?
|
| Aged | 7 | 2021 | 14862 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2020 | 2455 | 0.100 |
Why?
|
| Middle Aged | 8 | 2019 | 21147 | 0.100 |
Why?
|
| Focus Groups | 1 | 2012 | 247 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2279 | 0.100 |
Why?
|
| Mass Screening | 2 | 2009 | 843 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 446 | 0.090 |
Why?
|
| Prognosis | 2 | 2013 | 2093 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2011 | 74 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2021 | 7277 | 0.090 |
Why?
|
| Health Personnel | 2 | 2020 | 286 | 0.090 |
Why?
|
| Perception | 1 | 2011 | 189 | 0.090 |
Why?
|
| Papillomavirus Vaccines | 1 | 2011 | 93 | 0.090 |
Why?
|
| Academic Medical Centers | 2 | 2020 | 281 | 0.090 |
Why?
|
| Vaccination | 1 | 2011 | 189 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2020 | 502 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 378 | 0.080 |
Why?
|
| Students | 1 | 2011 | 233 | 0.080 |
Why?
|
| Male | 7 | 2020 | 37321 | 0.080 |
Why?
|
| Aromatase Inhibitors | 2 | 2019 | 17 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 194 | 0.080 |
Why?
|
| Pregnancy | 3 | 2020 | 2334 | 0.080 |
Why?
|
| Life Style | 1 | 2011 | 338 | 0.080 |
Why?
|
| Curriculum | 1 | 2012 | 575 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 546 | 0.080 |
Why?
|
| Health Promotion | 2 | 2020 | 407 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 4848 | 0.070 |
Why?
|
| Motivation | 1 | 2011 | 561 | 0.070 |
Why?
|
| Medically Underserved Area | 2 | 2005 | 85 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 3259 | 0.070 |
Why?
|
| Health Services Administration | 1 | 2005 | 11 | 0.070 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 102 | 0.060 |
Why?
|
| Nurse-Patient Relations | 1 | 2004 | 34 | 0.060 |
Why?
|
| Mexican Americans | 1 | 2004 | 30 | 0.060 |
Why?
|
| Employee Performance Appraisal | 1 | 2004 | 12 | 0.060 |
Why?
|
| Mobile Health Units | 1 | 2004 | 18 | 0.060 |
Why?
|
| Southwestern United States | 1 | 2003 | 5 | 0.060 |
Why?
|
| Ghana | 1 | 2003 | 40 | 0.060 |
Why?
|
| Community-Institutional Relations | 1 | 2004 | 59 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 1076 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2003 | 60 | 0.060 |
Why?
|
| Medically Uninsured | 1 | 2004 | 99 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 498 | 0.050 |
Why?
|
| Educational Status | 1 | 2004 | 273 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2005 | 322 | 0.050 |
Why?
|
| Neoplasms | 1 | 2013 | 1667 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2800 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 402 | 0.050 |
Why?
|
| Louisiana | 1 | 2021 | 37 | 0.050 |
Why?
|
| Cooperative Behavior | 2 | 2018 | 235 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 39 | 0.050 |
Why?
|
| Mammography | 1 | 2004 | 310 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2021 | 67 | 0.050 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2019 | 11 | 0.040 |
Why?
|
| Health Services | 1 | 2021 | 87 | 0.040 |
Why?
|
| Child Development | 1 | 2020 | 102 | 0.040 |
Why?
|
| Cultural Characteristics | 2 | 2014 | 42 | 0.040 |
Why?
|
| Vitamins | 1 | 2020 | 134 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 96 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 307 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 319 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 468 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 129 | 0.040 |
Why?
|
| Rooming-in Care | 1 | 2018 | 2 | 0.040 |
Why?
|
| Child Protective Services | 1 | 2018 | 9 | 0.040 |
Why?
|
| SEER Program | 1 | 2018 | 153 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 567 | 0.040 |
Why?
|
| Health Resources | 1 | 2018 | 76 | 0.040 |
Why?
|
| Environment | 1 | 2018 | 115 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 92 | 0.040 |
Why?
|
| Models, Economic | 1 | 2017 | 69 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 389 | 0.040 |
Why?
|
| Urine | 1 | 2016 | 47 | 0.040 |
Why?
|
| Culture | 1 | 2016 | 75 | 0.030 |
Why?
|
| Cancer Survivors | 1 | 2018 | 146 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 209 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1266 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 8912 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2018 | 413 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3187 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 711 | 0.030 |
Why?
|
| Risk Factors | 1 | 2021 | 5731 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2011 | 104 | 0.020 |
Why?
|
| Universities | 1 | 2011 | 191 | 0.020 |
Why?
|
| Social Environment | 1 | 2011 | 182 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1864 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2014 | 824 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2005 | 53 | 0.020 |
Why?
|
| Medicine, Traditional | 1 | 2004 | 7 | 0.020 |
Why?
|
| Mexico | 1 | 2004 | 38 | 0.020 |
Why?
|
| Models, Nursing | 1 | 2004 | 23 | 0.020 |
Why?
|
| Negotiating | 1 | 2004 | 18 | 0.020 |
Why?
|
| Prejudice | 1 | 2004 | 37 | 0.020 |
Why?
|
| Phytotherapy | 1 | 2004 | 53 | 0.010 |
Why?
|
| Poverty | 1 | 2005 | 219 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2004 | 85 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2004 | 180 | 0.010 |
Why?
|